Revolution Medicines Is Up Nearly 140% in 2026. Is the Hot Biotech Stock Still a Buy?
By
[email protected] (Adria Cimino)
2d agoen
Source
BarsRevolution Medicines Is Up Nearly 140% in 2026. Is the Hot Biotech Stock Still a Buy?fool.comThe company recently wowed investors with clinical trial results.
You might also wanna read
STAT+: Halfway into the year, biotech is booming
STAT·6d ago
STAT+: I spoke to Anthropic’s CEO about how AI may affect biotech. Here’s what I learned
STAT·2d ago
STAT+: Pharmalittle: We’re reading about a Novartis acquisition, Republicans backing clinical trial diversity, and more
STAT·2d ago
Do Semiconductor-Manufacturers' Stocks Really Mean that the Economic Future Is that Bright for Investment & Hence for Employment? Or Is It, This Time, Really, different? CHART OF THE DAY
open.substack.com·1mo ago
Biotech NRx to sell new shares to fund growth and operations
stocktitan.net·1mo ago
[Linkpost] “I Need You To Understand That “Moving Fast and Breaking Things” Is Playing With Peoples’ Lives” by Kenneth_Diao
EA Forum·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.